![]() |
市场调查报告书
商品编码
1949570
大肠直肠外科手术市场 - 全球产业规模、份额、趋势、机会及预测(按类型、产品、最终用户、地区和竞争格局划分),2021-2031年Colorectal Surgery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By End-User, By Region & Competition, 2021-2031F |
||||||
全球大肠直肠手术市场预计将从 2025 年的 194.5 亿美元成长到 2031 年的 308.4 亿美元,复合年增长率为 7.99%。
此细分市场涵盖用于诊断和治疗大肠直肠和肛门良恶性疾病(例如结肠癌和发炎性肠道疾病)的专用医疗设备和外科手术。市场扩张的主要原因是全球人口老化以及需要切除手术和结肠造口术的胃肠道疾病盛行率不断上升。根据美国癌症协会 (ACS) 估计,到 2025 年,美国新增大肠癌病例预计将达到 154,270 例。日益加重的疾病负担持续推高了对外科器械的需求,直接推动了市场成长。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 194.5亿美元 |
| 市场规模:2031年 | 308.4亿美元 |
| 复合年增长率:2026-2031年 | 7.99% |
| 成长最快的细分市场 | 低位前切除术 |
| 最大的市场 | 北美洲 |
然而,由于先进机器人系统和尖端电外科设备需要大量资本投资,市场面临许多障碍。这些高昂的实施和维修成本往往阻碍了微创手术技术在医疗基础设施欠发达地区的广泛应用,也阻碍了其在价格敏感地区的市场渗透。因此,医疗机构面临的巨大财务挑战可能会延缓手术室的现代化改造,并阻碍高品质大肠直肠疾病诊疗方案在全球范围内的普及。
全球大肠直肠癌和发炎性肠道疾病发生率的上升是推动大肠直肠外科手术市场发展的主要因素,刺激了对切除手术和治疗程序的需求成长。消化器官系统恶性肿瘤病情的日益严重迫使医疗机构加强外科手术能力,以满足越来越多需要复杂治疗的患者的需求。世界卫生组织(世卫组织)于2024年2月发布的题为《全球癌症负担》的新闻稿指出,大肠直肠癌是全球第二大癌症相关死亡原因,每年约造成90万人死亡。如此高的死亡率和发病率直接导致医院采购手术缝合器、能量器械和电外科设备的需求增加,以期透过及时的手术干预改善患者的治疗效果。
同时,机器人手术和微创手术技术的快速普及正在改变外科手术环境,带来更高的精准度和更短的恢復时间。这种转变推动了对先进机器人平台和相容器械的需求,尤其是在强调以价值为导向的先进医疗体系中。根据直觉外科公司(Intuitive Surgical)于2024年1月发布的“2023年第四季及全年财务业绩”,全球达文西手术量同比增长约22%,证实了机器人辅助手术在普通外科领域的快速普及。此外,筛检计画的扩展也加剧了这项手术需求。英国国家医疗服务体系(NHS England)报告称,2024年紧急癌症转诊病例达到创纪录的300万例,这将对结直肠外科资源产生显着的后续需求。
先进外科系统所需的高额资本投入是限制大肠直肠外科市场成长的主要阻碍因素。医疗机构,尤其是在开发中国家和公立医疗机构,往往缺乏足够的资金用于购买设备。机器人手术平台和现代电外科设备的高昂前期成本对许多医疗机构构成障碍,阻碍了它们从传统开放性手术转向微创技术。这种经济壁垒直接限制了设备的安装规模,从而减少了维持市场可持续收入所必需的专用器械的重复销售量。
营运负担超过了初始实施成本,这进一步阻碍了医院管理者对其外科设施进行现代化改造。据英国外科医师学会称,到2024年,机器人手术系统的资本支出至少为150万美元,此外每年还需要10万美元的持续维护成本。这些高昂的成本阻碍了市场渗透,製造商难以在对成本高度敏感的地区销售其高端技术。因此,市场成长缓慢,普及率仍集中在高所得地区。这使得全球相当一部分大肠直肠疾病治疗需求仍依赖传统的低成本调查方法。
某些结直肠手术转移到门诊手术中心(ASC)进行,代表着一种由节省成本和以患者为中心的医疗模式驱动的结构性变革。微创手术技术的进步使得诸如复杂切除术等手术能够在门诊环境中安全进行,而保险报销政策也倾向于选择成本较低的医疗机构。这种转变减轻了住院床位的压力,同时确保符合条件的病患的临床安全。正如Cardinal Health在2024年4月发表的题为《门诊手术中心的快速增长》的报导中所指出的,预计未来十年在门诊手术中心进行的手术数量将至少增长25%,该文章强调了这种去中心化的趋势。
人工智慧 (AI) 在外科手术决策支援中的应用,正将外科手术从机械辅助转变为数据驱动的智慧手术。製造商正将机器学习技术整合到内视镜系统中,以提供即时辅助,例如自动息肉检测,从而标准化治疗结果并减少操作者差异。这种整合透过提高筛检和切除过程中的诊断准确性来满足临床需求。根据 2024 年 11 月题为“Medtronic美国退伍军人事务部合同,以扩展 GI Genius AI 技术”的新闻稿,美国退伍军人事务部已签署合同,采购约 100 台额外的 AI 内视镜设备,这标誌着智能诊断设备在医疗机构中的应用正在加速普及。
The Global Colorectal Surgery Market is anticipated to expand from USD 19.45 Billion in 2025 to USD 30.84 Billion by 2031, reflecting a 7.99% CAGR. This sector encompasses specialized medical devices and surgical interventions designed to diagnose and treat benign and malignant ailments of the colon, rectum, and anus, such as colorectal cancer and inflammatory bowel disease. Market expansion is chiefly fueled by an increasingly aging global demographic and a growing prevalence of gastrointestinal disorders requiring resection or ostomy surgeries. According to the American Cancer Society, estimates suggested 154,270 new colorectal cancer diagnoses in the United States in 2025. This rising disease burden generates consistent demand for surgical tools, directly underpinning the market's growth trajectory.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 19.45 Billion |
| Market Size 2031 | USD 30.84 Billion |
| CAGR 2026-2031 | 7.99% |
| Fastest Growing Segment | Low Anterior Resection |
| Largest Market | North America |
However, the market encounters substantial obstacles due to the steep capital expenditure necessitated by advanced robotic systems and modern electrosurgical equipment. These high acquisition and upkeep costs frequently hinder the uptake of minimally invasive methods in developing healthcare infrastructures and constrain market penetration in price-sensitive geographies. As a result, significant financial hurdles within medical institutions can postpone the modernization of surgical suites and obstruct the wider dissemination of premium colorectal care solutions on a global scale.
Market Driver
The rising global incidence of colorectal cancer and inflammatory bowel disease acts as the primary catalyst for the colorectal surgery market, driving a greater need for resections and therapeutic measures. As the severity of gastrointestinal malignancies grows, healthcare providers are forced to bolster their surgical capacities to handle the volume of patients needing complex treatments. According to a World Health Organization press release in February 2024 titled 'Global Cancer Burden,' colorectal cancer stood as the second leading cause of cancer-related mortality globally, responsible for roughly 900,000 deaths. This high mortality and incidence rate leads directly to increased acquisition of surgical staplers, energy devices, and electrosurgical units as hospitals aim to enhance patient results through prompt surgical intervention.
Concurrently, the swift uptake of robotic and minimally invasive surgical methods is reshaping the procedural environment by delivering superior precision and faster recovery periods. This transition propels the demand for sophisticated robotic platforms and compatible tools, especially within developed healthcare systems that emphasize value-based care. According to Intuitive Surgical's 'Fourth Quarter and Full Year 2023 Financial Results' released in January 2024, worldwide da Vinci procedures increased by approximately 22% year-over-year, underscoring the quickening adoption of robotic aid in general surgery. Moreover, expanded screening programs are heightening this surgical need; NHS England reported delivering a record 3 million urgent cancer referrals in 2024, generating a significant downstream necessity for colorectal surgical resources.
Market Challenge
The substantial capital investment needed for advanced surgical systems acts as a major constraint on the colorectal surgery market's growth. Medical institutions, notably in developing countries and publicly funded networks, frequently function with limited budgets for capital equipment. The high initial costs for robotic platforms and contemporary electrosurgical units are prohibitive for numerous facilities, hindering the shift from conventional open surgery to minimally invasive techniques. This financial obstacle directly restricts the installed equipment base, which consequently diminishes the recurring sales volume of proprietary instruments required for sustained market revenue.
The operational strain extends past the initial acquisition, further discouraging hospital administrators from modernizing their surgical facilities. According to the Royal College of Surgeons of England, in 2024, the capital expense for a robotic surgical system was at least $1.5 million, accompanied by recurring annual maintenance fees of $100,000. These steep costs generate a gap in market penetration, as manufacturers face challenges selling premium technologies in cost-conscious regions. Consequently, the market sees decelerated growth rates as adoption remains focused in high-income areas, leaving a significant segment of global colorectal care demand dependent on older, less costly methodologies.
Market Trends
The shift of specific colorectal procedures to Ambulatory Surgery Centers (ASCs) signifies a structural evolution motivated by cost reduction and patient-centered care models. Improvements in minimally invasive methods now permit the safe execution of interventions such as complex polypectomies in outpatient environments, encouraged by reimbursement policies that favor lower-cost locations. This move relieves pressure on inpatient capacity while upholding clinical safety standards for suitable patients. As stated in the 'Rapid growth for ambulatory surgery centers' article by Cardinal Health in April 2024, the volume of surgical procedures conducted in ASCs is expected to increase by at least 25% over the coming decade, emphasizing the momentum of this decentralization trend.
The implementation of Artificial Intelligence for surgical decision support is transforming the sector, shifting it from mechanical aid to data-driven intelligent surgery. Manufacturers are embedding machine learning into endoscopic systems to offer real-time assistance, such as automated polyp detection, which normalizes outcomes and lessens operator variability. This incorporation meets clinical demands by improving diagnostic precision during screening and resection. According to the 'Medtronic awarded VA contract to expand GI Genius AI technology' press release from November 2024, the U.S. Department of Veterans Affairs concluded an agreement to install nearly 100 additional AI-enabled endoscopy units, highlighting the quickening institutional uptake of intelligent diagnostic instruments.
Report Scope
In this report, the Global Colorectal Surgery Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Colorectal Surgery Market.
Global Colorectal Surgery Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: